Kreditanstalt für Wiederaufbau (KfW) has joined existing lead investors MIG AG and Co KG Beteiligungsfonds 3 and S-Venture Capital Dortmund GmbH in raising EUR 1m in interim financing for protein research company Protagen AG. This is the third round of funding for the company. Protagen is a provider of products, services and software solutions for protein research. Recently, Protagen has received a BioChance Plus grant from the German government to identify biomarkers for multiple sclerosis and rheumatoid arthritis. The company is headquartered in Dortmund, and has a second office in New Jersey, US. At present, it employs a staff of 25.
Company plans on expanding further into the learning and development market
Primomiglio, Banca di Piacenza, Intesa Sanpaolo Vita, Be Shaping the Future and CRIF also take part in the round
Centerbridge Partners, which invested in the company in 2013, retains a minority stake
Company will use the proceeds to commercialise its flagship product across the US